Perspective Therapeutics (CATX) Shares Issued (2011 - 2025)

Perspective Therapeutics (CATX) has 15 years of Shares Issued data on file, last reported at $5.4 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Issued fell 26.02% year-over-year to $5.4 million; the trailing twelve-month figure through Dec 2025 stood at $5.4 million (down 26.02% YoY), and the FY2025 full-year result was $5.4 million, down 26.02% from the prior year.
• Shares Issued eased to $5.4 million in Q4 2025, from $7.4 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $44.9 million in Q2 2023 to a low of $3.4 million in Q1 2021.
• A 5-year average of $14.0 million and a median of $7.1 million in 2021 frame the typical range for Shares Issued.
• Peak annual rise in Shares Issued reached 837.13% in 2023, while the deepest fall reached 52.68% in 2023.
• Tracing CATX's Shares Issued over 5 years: stood at $7.3 million in 2021, then surged by 48.68% to $10.8 million in 2022, then plunged by 52.68% to $5.1 million in 2023, then jumped by 43.79% to $7.4 million in 2024, then fell by 26.02% to $5.4 million in 2025.
• Business Quant data shows CATX's Shares Issued at $5.4 million in Q4 2025, $7.4 million in Q4 2024, and $5.1 million in Q4 2023.